Nano-Immunoengineering: Programmable Nanoparticles for Remodeling Immune Checkpoints in Cancer
2026 | NEWPORT INTERNATIONAL JOURNAL OF ENGINEERING AND PHYSICAL SCIENCES (NIJEP) | Pp. 18-23
Immune checkpoint blockade has revolutionized cancer therapy by reactivating antitumor immunity, yet durable clinical responses remain limited to a subset of patients. Resistance arises from immune-suppressive tumor microenvironments, systemic toxicity, inade...